StockClub

CATX

CATXPerspective Therapeutics, Inc.$ --
Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc.

CATX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY +Infinity%
Operating Income
-28M USD
YoY -29.5%
Net Income
-26M USD
YoY -44.1%
EPS
-0.25$
YoY 0.0%

Revenue

$76,000
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$290,000
$290,000
Q2
FY2025 Q3$499,000
$499,000
Q3
FY2025 Q4$499,000
$499,000
Q4
FY2026 Q1$76,000
$76,000
Q1
Actual
+$76,000 (-)

Net Income

$-26.2M
FY2024 Q2$-24M
$-24M
Q2
FY2024 Q3$-39.1M
$-39.1M
Q3
FY2024 Q4$-79.3M
$-79.3M
Q4
FY2025 Q1$-18.2M
$-18.2M
Q1
FY2025 Q2$-39.7M
$-39.7M
Q2
FY2025 Q3$-65.6M
$-65.6M
Q3
FY2025 Q4$-103.1M
$-103.1M
Q4
FY2026 Q1$-26.2M
$-26.2M
Q1
Actual
$-8M (-44.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$10.1M
Est:$10.1M
FY2020MISS
$10.1M
FY2021BEAT
Actual:$10.8M
Est:$10M
FY2021BEAT
$10.8M
FY2022MISS
Actual:$7.1M
Est:$11.1M
FY2022MISS
$7.1M
FY2023BEAT
Actual:$1.4M
Est:$1.4M
FY2023BEAT
$1.4M
FY2024MISS
Actual:$0
Est:$1.4M
FY2024MISS
$0
FY2025MISS
Actual:$0
Est:$1.1M
FY2025MISS
$0

Analyst Estimates